{"id":70032,"date":"2025-06-16T07:01:00","date_gmt":"2025-06-15T23:01:00","guid":{"rendered":"http:\/\/www.upgrademag.com\/web\/?p=70032"},"modified":"2025-06-08T10:03:11","modified_gmt":"2025-06-08T02:03:11","slug":"oracle-enables-automation-of-drug-supply-management-across-vendors","status":"publish","type":"post","link":"http:\/\/www.upgrademag.com\/web\/2025\/06\/16\/oracle-enables-automation-of-drug-supply-management-across-vendors\/","title":{"rendered":"Oracle enables automation of drug supply management across vendors"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>New interoperability advancements in Oracle\u2019s enterprise-grade\u00a0<a href=\"https:\/\/www.oracle.com\/ph\/life-sciences\/clinical-trials\/clinical-one-randomization-supplies-management\/\">Randomization and Trial Supply Management (RTSM)<\/a>\u00a0solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This aids in reducing inefficiencies and waste, and accelerating trial execution timelines. In addition, Oracle RTSM now supports fully integrated supply management with SAP, Almac, Fisher Clinical Services, Catalent, and PMD\u2014to help the right drug reach the right site at the right time, regardless of the study\u2019s technology platform.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Built on the security, performance and scalability of&nbsp;<a href=\"https:\/\/www.oracle.com\/ph\/cloud\/\">Oracle Cloud Infrastructure<\/a>&nbsp;(OCI), RTSM delivers end-to-end automation for drug supply ordering, tracking, and allocation across RTSM systems and clinical sites. This supports a growing demand for multi-vendor strategies and cross-trial flexibility. RTSM also offers built in analytics to provide centralized inventory levels, shipment statuses, and drug usage across the user\u2019s trial portfolio and multiple workflow streams. RTSM is part of Oracle\u2019s broad portfolio of integrated&nbsp;<a href=\"https:\/\/www.oracle.com\/ph\/life-sciences\/\">clinical trial applications<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These changes reflect Oracle\u2019s strategy of prioritizing interoperability, connectivity, AI-driven automation, and agentic workflows. This approach underpins Oracle\u2019s vision to unify its life sciences and clinical applications, such as electronic health records, to create an intelligent, continuously learning ecosystem that can help accelerate innovation, reduce costs, and improve care. In this environment, hospitals will be able to initiate trials quickly, identify eligible patients at the point of care, and continuously capture real-world data\u2014making research more connected, intelligent, and patient-centric.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cOur latest enhancements reflect Oracle\u2019s continued commitment to interoperability and to delivering an open and connected ecosystem\u2014empowering sponsors to accelerate innovation, reduce complexity, and drive better outcomes for patients,\u201d said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. \u201cToday&#8217;s clinical trials often span multiple studies, systems, and vendors. By enabling drug pooling and supply management automation across platforms, we\u2019re helping organizations manage inventory more efficiently, optimize resources, and move promising therapies forward faster.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For more information about Oracle\u2019s integrated clinical trial portfolio and services, visit&nbsp;<a href=\"https:\/\/www.oracle.com\/ph\/life-sciences\/clinical-trials\/clinical-data-management\/\">oracle.com\/life<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. <\/p>\n","protected":false},"author":6,"featured_media":46350,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[290,96,2727,1656],"class_list":["post-70032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-headlines","tag-oracle","tag-technology","tag-technology-adaption","tag-technology-investment"],"_links":{"self":[{"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/posts\/70032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/comments?post=70032"}],"version-history":[{"count":1,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/posts\/70032\/revisions"}],"predecessor-version":[{"id":70033,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/posts\/70032\/revisions\/70033"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/media\/46350"}],"wp:attachment":[{"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/media?parent=70032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/categories?post=70032"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.upgrademag.com\/web\/wp-json\/wp\/v2\/tags?post=70032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}